A multicentre analysis of Nocardia pneumonia in Spain: 2010-2016

dc.contributor.authorErcibengoa, María
dc.contributor.authorCàmara, Jordi
dc.contributor.authorTubau, Fe
dc.contributor.authorGarcía Somoza, Dolors
dc.contributor.authorGalar, Alicia
dc.contributor.authorMartín Rabadán, Pablo
dc.contributor.authorMarin, Mercedes
dc.contributor.authorMateu, Lourdes
dc.contributor.authorGarcía Olivé, Ignasi
dc.contributor.authorPrat, Cristina
dc.contributor.authorCillóniz, Catia
dc.contributor.authorTorres Martí, Antoni
dc.contributor.authorPedro Botet, Maria Luisa
dc.contributor.authorArdanuy Tisaire, María Carmen
dc.contributor.authorMuñoz, Patricia
dc.contributor.authorMarimón, José María
dc.date.accessioned2021-02-05T14:15:16Z
dc.date.available2021-02-05T14:15:16Z
dc.date.issued2020
dc.date.updated2021-02-05T14:15:16Z
dc.description.abstractObjective: To analyse all cases of Nocardia pneumonia occurring between 2010 and 2016 in five Spanish hospitals. Methods: This was a retrospective observational analysis of clinical and microbiological data collected from 55 cases of Nocardia pneumonia. Results: There were one to 20 cases per hospital and six to nine cases per year. Chronic obstructive pulmonary disease, bronchiectasis, and asthma were the main predisposing underlying respiratory conditions. Thirty-four patients were receiving systemic and/or inhaled corticosteroids prior to infection, eight had neoplasia, and six had haematological malignancies. Clinical and radiological findings were common to pneumonia of other infectious aetiologies, except for the frequent presence of nodules and cavitation. Overall, the 1-year mortality was high (38.2%), and mortality was directly related to the pulmonary disease in 15 patients (27.3%). The most frequently identified species were N. cyriacigeorgica (n = 21), N. abscessus (n = 8), and N. farcinica (n = 5). All Nocardia isolates were susceptible to linezolid and all but two were susceptible to amikacin and trimethoprim-sulfamethoxazole. Conclusions: Nocardia pneumonia-associated mortality remains high, probably because of the debilitated status of patients in whom this pathogen is able to cause pulmonary infection.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec700168
dc.identifier.issn1201-9712
dc.identifier.urihttps://hdl.handle.net/2445/173705
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.ijid.2019.10.032
dc.relation.ispartofInternational Journal of Infectious Diseases, 2020, vol. 90, p. 161-166
dc.relation.urihttps://doi.org/10.1016/j.ijid.2019.10.032
dc.rightscc-by-nc-nd (c) Ercibengoa, Maria et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationPneumònia
dc.subject.classificationInfeccions respiratòries
dc.subject.otherPneumonia
dc.subject.otherRespiratory infections
dc.titleA multicentre analysis of Nocardia pneumonia in Spain: 2010-2016
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
700168.pdf
Mida:
382.18 KB
Format:
Adobe Portable Document Format